Cargando…

Transcriptional level of inflammation markers associates with short-term brain structural changes in first-episode schizophrenia

BACKGROUND: Inflammation has been implicated in the pathology of schizophrenia and may cause neuronal cell death and dendrite loss. Neuroimaging studies have highlighted longitudinal brain structural changes in patients with schizophrenia, yet it is unclear whether this is related to inflammation. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Long-Biao, Wang, Xian-Yang, Fu, Yu-Fei, Liu, Xiao-Fan, Wei, Yongbin, Zhao, Shu-Wan, Gu, Yue-Wen, Fan, Jing-Wen, Wu, Wen-Jun, Gong, Hengfen, Lin, Bochao Danae, Yin, Hong, Guan, Fanglin, Chang, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332052/ https://www.ncbi.nlm.nih.gov/pubmed/37424013 http://dx.doi.org/10.1186/s12916-023-02963-y

Ejemplares similares

Differential expression of diacylglycerol kinase ζ is involved in inferior parietal lobule-related dysfunction in schizophrenia with cognitive impairments
por: Liu, Xiao-Fan, et al.
Publicado: (2023)

Follow-up of N400 in the Rehabilitation of First-episode Schizophrenia
por: Du, Xiang-Dong, et al.
Publicado: (2015)

Inflammatory markers of symptomatic remission at 6 months in patients with first-episode schizophrenia
por: Kim, Honey, et al.
Publicado: (2023)

Impact of childhood trauma on sensory gating in patients with first-episode schizophrenia
por: Li, Xian-Bin, et al.
Publicado: (2018)

Anterior cingulate cortex-related connectivity in first-episode schizophrenia: a spectral dynamic causal modeling study with functional magnetic resonance imaging
por: Cui, Long-Biao, et al.
Publicado: (2015)

Aberrant perfusion and its connectivity within default mode network of first-episode drug-naïve schizophrenia patients and their unaffected first-degree relatives
por: Cui, Long-Biao, et al.
Publicado: (2017)

Phenome-wide and genome-wide analyses of quality of life in schizophrenia
por: Pazoki, Raha, et al.
Publicado: (2020)

The Association Between Lentiform Nucleus Function and Cognitive Impairments in Schizophrenia
por: Li, Ping, et al.
Publicado: (2021)

Transcriptomics and magnetic resonance imaging in major psychiatric disorders
por: Fan, Jing-Wen, et al.
Publicado: (2023)

DNA methylation levels of RELN promoter region in ultra-high risk, first episode and chronic schizophrenia cohorts of schizophrenia
por: Kho, Sok-Hong, et al.
Publicado: (2022)

Phenome-wide and genome-wide analyses of quality of life in schizophrenia – ERRATUM
por: Pazoki, Raha, et al.
Publicado: (2021)

Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study
por: Chen, Xiaofang, et al.
Publicado: (2023)

Cost-utility analysis of using paliperidone palmitate in schizophrenia in China
por: Luo, Rui, et al.
Publicado: (2023)

Volume alteration of hippocampal subfields in first-episode antipsychotic-naïve schizophrenia patients before and after acute antipsychotic treatment
por: Li, Wenbin, et al.
Publicado: (2018)

Increased Markers of Oxidative Stress and Positive Correlation Low-Grade Inflammation with Positive Symptoms in the First Episode of Schizophrenia in Drug-Naïve Patients
por: Dudzińska, Ewa, et al.
Publicado: (2022)

Effects of short-term inpatient treatment on sensitivity to a size contrast illusion in first-episode psychosis and multiple-episode schizophrenia
por: Silverstein, Steven M., et al.
Publicado: (2013)

Latent Iron Deficiency as a Marker of Negative Symptoms in Patients with First-Episode Schizophrenia Spectrum Disorder
por: Kim, Sung-Wan, et al.
Publicado: (2018)

Subpopulation composition of monocytes and inflammation markers in schizophrenia
por: Zozulya, S. A., et al.
Publicado: (2023)

Age-associated network controllability changes in first episode drug-naïve schizophrenia
por: Tang, Biqiu, et al.
Publicado: (2022)

Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal fMRI Study
por: Hu, Mao-Lin, et al.
Publicado: (2016)

Stage-Specific Brain Aging in First-Episode Schizophrenia and Treatment-Resistant Schizophrenia
por: Kim, Woo-Sung, et al.
Publicado: (2022)

First episode-psychosis: Short- and long-term outcomes and related features predicting the transition to schizophrenia
por: Jabeur, M., et al.
Publicado: (2022)

Genome wide association study identifies four loci for early onset schizophrenia
por: Guo, Suqin, et al.
Publicado: (2021)

Impaired Emotional Self-Referential Processing in First-Episode Schizophrenia
por: Zhao, Yanli, et al.
Publicado: (2021)

Impaired interactions among white‐matter functional networks in antipsychotic‐naive first‐episode schizophrenia
por: Fan, Yun‐Shuang, et al.
Publicado: (2019)

Glucose metabolism, hippocampal subfields and cognition in first-episode and never-treated schizophrenia
por: Xiu, Meihong, et al.
Publicado: (2023)

Treatment Response in First-episode Schizophrenia
por: Schennach, Rebecca, et al.
Publicado: (2012)

The neurobiology and treatment of first-episode schizophrenia
por: Kahn, R S, et al.
Publicado: (2015)

Dysexecutive Behavior in First-Episode Schizophrenia
por: Orellana, Gricel, et al.
Publicado: (2022)

The Role of Butyric Acid in Treatment Response in Drug-Naïve First Episode Schizophrenia
por: Li, Xue, et al.
Publicado: (2021)

Reliability and validity of the Chinese version of the Childhood Trauma Questionnaire-Short Form for inpatients with schizophrenia
por: Jiang, Wen-Juan, et al.
Publicado: (2018)

Controllability of Functional Brain Networks and Its Clinical Significance in First-Episode Schizophrenia
por: Li, Qian, et al.
Publicado: (2022)

The Therapeutic Effects of a PEDF-Derived Short Peptide on Murine Experimental Dry Eye Involves Suppression of MMP-9 and Inflammation
por: Ho, Tsung-Chuan, et al.
Publicado: (2022)

PM475. White matter abnormalities and their associations with clinical symptoms in first episode and drug-naïve patients with schizophrenia
por: Zhang, Xiang-Yang, et al.
Publicado: (2016)

Antipsychotic drugs increase Neuregulin1β1 serum levels in first-episode drug-naïve patients and chronic schizophrenia with suggestions for improving the treatment of psychotic symptoms
por: Yang, Haidong, et al.
Publicado: (2022)

Brain function differences in drug-naïve first-episode auditory verbal hallucination-schizophrenia patients with versus without insight
por: Chen, Min, et al.
Publicado: (2019)

Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
por: Chen, Lei, et al.
Publicado: (2021)

Serum Level of Growth-Associated Protein 43 Is Associated with First-Episode Schizophrenia Patients without Antipsychotic Drugs Treatment
por: Xiao, Libin, et al.
Publicado: (2022)

Disease-relevant autoantibodies in first episode schizophrenia
por: Zandi, Michael S., et al.
Publicado: (2010)

Distinct Episodic Verbal Memory Profiles in Schizophrenia
por: Brazo, Perrine, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rfp8g1p12pdt8audikddooovpa